← Product Code [FOZ](/productcode/FOZ) · K963196

# VYGON UMBILICAL CATHETHER INSERTION TRAY (K963196)

_Vygon Corp. · FOZ · Sep 9, 1997 · General Hospital · SESE_

**Canonical URL:** https://fda-staging.innolitics.com/device/K963196

## Device Facts

- **Applicant:** Vygon Corp.
- **Product Code:** [FOZ](/productcode/FOZ.md)
- **Decision Date:** Sep 9, 1997
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 880.5200
- **Device Class:** Class 2
- **Review Panel:** General Hospital
- **Attributes:** Pediatric

## Indications for Use

Venous arterial umbilical access in infants.

## Device Story

Vygon Umbilical Catheter Insertion Tray (2.5 Fr. and 3.5 Fr.) is a procedural kit designed for venous or arterial umbilical access in infants. The tray contains various medical components, including catheters and sutures, intended to facilitate the insertion procedure. The device is used in a clinical setting by healthcare professionals. The kit is provided sterile; components must be sourced from legally marketed devices. The inclusion of drug components (e.g., betadine swabsticks) requires separate regulatory compliance with the Center for Drug Evaluation and Research.

## Clinical Evidence

No clinical data provided; substantial equivalence is based on the regulatory status of the individual components within the tray.

## Technological Characteristics

Procedural kit containing catheters (2.5 Fr., 3.5 Fr.) and sutures. Components are sterilized; suture characteristics are verified to remain unaltered by the sterilization process. Kit includes drug components (betadine swabsticks).

## Regulatory Identification

An intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings and that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. The device may be constructed of metal, rubber, plastic, or a combination of these materials.

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850

SEP - 9 1997

Ms. Anne Marie Cesario
Director, Regulatory Affairs
Vygon Corporation
One Madison Street
East Rutherford, New Jersey 07073

Re: K963196
Trade Name: Vygon Umbilical Catheter Insertion Tray
(2.5 Fr., 3.5 Fr.)
Regulatory Class: II
Product Code: FOZ
Dated: June 12, 1997
Received: June 17, 1977

Dear Ms. Cesario:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act). You may, therefore, market the device, subject to the general controls provisions of Act. However, you are responsible to determine that the medical devices you use as components in the tray have either been determined as substantially equivalent under the premarket notification process (Section 510(k) of the act), or were on the market prior to May 28, 1976, the enactment date of the Medical Device Amendments. Please note: If you purchase your device components in bulk (i.e., unfinished) and further process (e.g., sterilize) you must submit a new 510(k) before including these components in your tray. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the

{1}

Page 2 - Ms. Cesario

Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, FDA will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the *Federal Register*. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

FDA notes that your device will contain sutures for which you have provided evidence that the suture characteristics are not altered by the sterilization process used for the device. However, you should be aware of the following additional information regarding the inclusion of a suture as a component of your device:

1. The labeling, packaging and method of sterilization of the suture cannot be changed without prior notification, review and clearance by FDA.
2. The supplier of the sutures used in your device cannot be changed without prior notification, review and clearance by FDA.

In addition, we have determined that your device kit contains betadine swabsticks which are subject to regulation as a drugs.

Our substantially equivalent determination does not apply to the drug component of your device. We recommend you first contact the Center for Drug Evaluation and Research before marketing your device with the drug component. For information on applicable Agency requirements for marketing this drug, we suggest you contact:

Director, Division of Drug Labeling Compliance (HFD-310)
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, Maryland 20857
(301) 594-0101

{2}

Page 3 - Ms. Cesario

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809 for *in vitro* diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act, may be obtained from the Division of Small Manufacturers Assistance at its toll free number (800) 638-2041 or (301) 443-6597, or at its internet address http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

![img-0.jpeg](img-0.jpeg)

Timothy A. Ulatowski
Director
Division of Dental, Infection Control, and General Hospital Devices
Office of Device Evaluation
Center for Devices and Radiological Health

Enclosure

{3}

K963196-Vygon Umbilical Catheter Insertion Tray (2.5 Fr., 3.5 Fr.)
Response to FDA Questions Dated November 19, 1996

510(k) Number (if known): K963196

Device Name: Vygon Umbilical Catheter Insertion Tray (2.5 Fr. & 3.5 Fr.)

Indications for Use:
Venous arterial umbilical access in infants.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Patella Cucin
(Division Sign-Off)
Division of Dental, Infection Control, and General Hospital Devices
510(k) Number K963196

Prescription Use ☑ or Over-The-Counter Use ☐
(Per 21 CFR 801.109)
(Optional Format 1-2-96)

Submitted by Schiff & Company®
Page 7

---

**Source:** [https://fda-staging.innolitics.com/device/K963196](https://fda-staging.innolitics.com/device/K963196)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com